{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:56Z","timestamp":1707524516993},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.7759\/cureus.23732","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:53:59Z","timestamp":1648821239000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Varicella or Herpes Zoster? An Educational Case Report From the Primary Care Clinic"],"prefix":"10.7759","author":[{"given":"Ana K","family":"G\u00f3mez-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areli A","family":"Flores-Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Casillas Fikentscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eder","family":"Luna-Ceron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin S","year":"2014","unstructured":"Plotkin S. History of vaccination. Proc Natl Acad Sci U S A. 2014, 111:12283-7. 10.1073\/pnas.1400472111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7043a1","article-title":"Routine vaccination coverage - worldwide, 2020","volume":"70","author":"Muhoza P","year":"2021","unstructured":"Muhoza P, Danovaro-Holliday MC, Diallo MS, Murphy P, Sodha SV, Requejo JH, Wallace AS. Routine vaccination coverage - worldwide, 2020. MMWR Morb Mortal Wkly Rep. 2021, 70:1495-500. 10.15585\/mmwr.mm7043a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","unstructured":"WHO UNICEF Immunization Coverage Estimates 2020 revision. (2021). https.\/\/www.who.int\/docs\/default-source\/immunization\/immunization-coverage\/wuenic_notes.pdf?sfvrsn=88ff590d_6."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1353","article-title":"Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis","volume":"315","author":"Phadke VK","year":"2016","unstructured":"Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA. 2016, 315:1149-58. 10.1001\/jama.2016.1353","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1905099","article-title":"Measles in 2019 - going backward","volume":"380","author":"Paules CI","year":"2019","unstructured":"Paules CI, Marston HD, Fauci AS. Measles in 2019 - going backward. N Engl J Med. 2019, 380:2185-7. 10.1056\/NEJMp1905099","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-019-03066-x","article-title":"New immunization strategies: adapting to global challenges","volume":"63","author":"Mantel C","year":"2020","unstructured":"Mantel C, Cherian T. New immunization strategies: adapting to global challenges. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020, 63:25-31. 10.1007\/s00103-019-03066-x","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.11150\/kansenshogakuzasshi1970.71.1113","article-title":"[Varicella in adulthood: clinical features, severity scores, source of infection and complications]","volume":"71","author":"Takayama N","year":"1997","unstructured":"Takayama N, Ajisawa A, Negishi M, Masuda G, Minamitani M. [Varicella in adulthood: clinical features, severity scores, source of infection and complications]. Kansenshogaku Zasshi. 1997, 71:1113-9. 10.11150\/kansenshogakuzasshi1970.71.1113","journal-title":"Kansenshogaku Zasshi"},{"key":"ref8","article-title":"Varicella and its complications as cause of hospitalization","volume":"13","author":"Losurdo G","year":"2005","unstructured":"Losurdo G, Bertoluzzo L, Canale F, Timitilli A, Bondi E, Castagnola E, Giacchino R. Varicella and its complications as cause of hospitalization. Infez Med. 2005, 13:229-34.","journal-title":"Infez Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon AA","year":"2015","unstructured":"Gershon AA, Breuer J, Cohen JI, et al.. Varicella zoster virus infection. Nat Rev Dis Primers. 2015, 1:15016. 10.1038\/nrdp.2015.16","journal-title":"Nat Rev Dis Primers"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo PW","year":"1995","unstructured":"Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995, 172:706-12. 10.1093\/infdis\/172.3.706","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20131775","article-title":"Review: dermatitis herpetiformis","volume":"88","author":"Mendes FB","year":"2013","unstructured":"Mendes FB, Hissa-Elian A, Abreu MA, Gon\u00e7alves VS. Review: dermatitis herpetiformis. An Bras Dermatol. 2013, 88:594-9. 10.1590\/abd1806-4841.20131775","journal-title":"An Bras Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley RJ","year":"2001","unstructured":"Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001, 357:1513-8. 10.1016\/S0140-6736(00)04638-9","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2006.05021","article-title":"Dyshidrosis: epidemiology, clinical characteristics, and therapy","volume":"17","author":"Lofgren SM","year":"2006","unstructured":"Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis. 2006, 17:165-81. 10.2310\/6620.2006.05021","journal-title":"Dermatitis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00271-4","article-title":"Contact dermatitis","volume":"7","author":"Scheinman PL","year":"2021","unstructured":"Scheinman PL, Vocanson M, Thyssen JP, et al.. Contact dermatitis. Nat Rev Dis Primers. 2021, 7:38. 10.1038\/s41572-021-00271-4","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni L","year":"2014","unstructured":"Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol. 2014, 12:197-210. 10.1038\/nrmicro3215","journal-title":"Nat Rev Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2445-2","article-title":"Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization","volume":"17","author":"Riera-Montes M","year":"2017","unstructured":"Riera-Montes M, Bollaerts K, Heininger U, et al.. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017, 17:353. 10.1186\/s12879-017-2445-2","journal-title":"BMC Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/315492","article-title":"Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era","volume":"181","author":"Lin F","year":"2000","unstructured":"Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis. 2000, 181:1897-905. 10.1086\/315492","journal-title":"J Infect Dis"},{"key":"ref18","article-title":"Varicella zoster virus. Recent advances in management","volume":"47","author":"Rajan P","year":"2001","unstructured":"Rajan P, Rivers JK. Varicella zoster virus. Recent advances in management. Can Fam Physician. 2001, 47:2299-304.","journal-title":"Can Fam Physician"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_1021_16","article-title":"Epidemiology, treatment and prevention of herpes zoster: a comprehensive review","volume":"84","author":"Koshy E","year":"2018","unstructured":"Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 2018, 84:251-62. 10.4103\/ijdvl.IJDVL_1021_16","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1302674","article-title":"Clinical practice: herpes zoster","volume":"369","author":"Cohen JI","year":"2013","unstructured":"Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013, 369:255-63. 10.1056\/NEJMcp1302674","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2298\/vsp1007523d","article-title":"[Varicella complications: is it time to consider a routine varicella vaccination?]","volume":"67","author":"Dulovi\u0107 O","year":"2010","unstructured":"Dulovi\u0107 O, Gvozdenovi\u0107 E, Nikoli\u0107 J, Spurni\u0107 AR, Katani\u0107 N, Kovarevi\u0107-Pavi\u0107evi\u0107 D. [Varicella complications: is it time to consider a routine varicella vaccination?]. Vojnosanit Pregl. 2010, 67:523-9. 10.2298\/vsp1007523d","journal-title":"Vojnosanit Pregl"},{"key":"ref22","article-title":"Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"Freer G","year":"2018","unstructured":"Freer G, Pistello M. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018, 41:95-105.","journal-title":"New Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-013-0246-5","article-title":"Complications of varicella zoster virus reactivation","volume":"15","author":"Nagel MA","year":"2013","unstructured":"Nagel MA, Gilden D. Complications of varicella zoster virus reactivation. Curr Treat Options Neurol. 2013, 15:439-53. 10.1007\/s11940-013-0246-5","journal-title":"Curr Treat Options Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03080190138035","article-title":"Varicella pneumonia: study of prevalence in adult men","volume":"192","author":"Weber DM","year":"1965","unstructured":"Weber DM, Pellecchia JA. Varicella pneumonia: study of prevalence in adult men. JAMA. 1965, 192:572-3. 10.1001\/jama.1965.03080190138035","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2019.10.034","article-title":"Rare presentation of primary varicella zoster as fatal fulminant hepatitis in adult on low-dose, short-term steroid: case report","volume":"48","author":"Toffaha A","year":"2019","unstructured":"Toffaha A, El Ansari W, Ramzee AF, Afana M, Aljohary H. Rare presentation of primary varicella zoster as fatal fulminant hepatitis in adult on low-dose, short-term steroid: case report. Ann Med Surg (Lond). 2019, 48:115-7. 10.1016\/j.amsu.2019.10.034","journal-title":"Ann Med Surg (Lond)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890410517","article-title":"Treatment of varicella in the immunocompetent adult","volume":"1","author":"Wallace MR","year":"1993","unstructured":"Wallace MR, Bowler WA, Oldfield EC 3rd. Treatment of varicella in the immunocompetent adult. J Med Virol. 1993, 1:90-2. 10.1002\/jmv.1890410517","journal-title":"J Med Virol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447010-00009","article-title":"Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy","volume":"47","author":"Wagstaff AJ","year":"1994","unstructured":"Wagstaff AJ, Faulds D, Goa KL. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1994, 47:153-205. 10.2165\/00003495-199447010-00009","journal-title":"Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80456-primary-varicella-or-herpes-zoster-an-educational-case-report-from-the-primary-care-clinic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:43Z","timestamp":1707507403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80456-primary-varicella-or-herpes-zoster-an-educational-case-report-from-the-primary-care-clinic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.23732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}